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Abstract
Background: Brain-expressed proteins that have undergone functional change during human evolution may
contribute to human cognitive capacities, and may also leave us vulnerable to specifically human diseases, such as
schizophrenia, autism or Alzheimer’s disease. In order to search systematically for those proteins that have changed
the most during human evolution and that might contribute to brain function and pathology, all proteins with
orthologs in chimpanzee, orangutan and rhesus macaque and annotated as being expressed on the surface of cells
in the human central nervous system were ordered by the number of human-specific amino acid differences that
are fixed in modern populations.
Results: PCDHB11, a beta-protocadherin homologous to murine cell adhesion proteins, stood out with 12
substitutions and maintained its lead after normalizing for protein size and applying weights for amino acid
exchange probabilities. Human PCDHB11 was found to cause homophilic cell adhesion, but at lower levels than
shown for other clustered protocadherins. Homophilic adhesion caused by a PCDHB11 with reversion of human-
specific changes was as low as for modern human PCDHB11; while neither human nor reverted PCDHB11 adhered
to controls, they did adhere to each other. A loss of function in PCDHB11 is unlikely because intra-human variability
did not increase relative to the other human beta-protocadherins.
Conclusions: The brain-expressed protein with the highest number of human-specific substitutions is PCDHB11. In
spite of its fast evolution and low intra-human variability, cell-based tests on the only proposed function for
PCDHB11 did not indicate a functional change.
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Background
Human brains are different from other primate brains.
However, it is not clear if the difference is simply a mat-
ter of size [1] or if there are any molecular and cellular
differences that would help explain uniquely human cap-
abilities. One molecular difference that might be import-
ant for the acquisition of such a capability, namely of
speech, is the substitution of two amino acids in the pro-
tein FOXP2 [2–4]. Other human-specific differences
have been discovered in proteins expressed in the brain,
but have not yet been linked to a behavioral phenotype
[5–8].
It has been surmised for more than 30 years that the
main genetic differences between humans and chimpan-
zees lie in regulatory sequences [9], and recent studies
have begun to identify some of the more relevant
human-specific elements [10–13]. However, even with
the increasing number of sequenced human and other
primate genomes, it remains more difficult to identify
functionally relevant differences in non-coding parts of
the genome, even in well-studied transcription factor
binding sites [14], than in protein-coding sequences.
Therefore, the present study concentrates on differences
in the protein-coding parts of the genome.
While the genomes of individuals from extinct human
populations are exciting sources of information on hu-
man evolution [15–19], we lack reliable information on
the cognitive capabilities of those populations [20, 21].
Therefore, the most useful comparison is with living pri-
mates, on whose cognitive phenotype we do have infor-
mation [22, 23]: a DNA variant might contribute to
human cognitive capabilities if it is present in all cogni-
tively normal modern humans, but not in the aligned
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genomes of other primates. The analysis of primate ge-
nomes has yielded lists of such variants [24–27]; how-
ever, the statistical tests for positive selection are
necessarily of low statistical power and selectivity, and
the necessary biochemical analysis of such candidate
genes has rarely been reported [28].
The initial auto-organization of the human brain and
its subsequent forming by the environment are mediated
by cell surface proteins [29–31]. Variation in adhesion
proteins has been shown to degrade [32] and, possibly,
to explain part of normal variation in cognitive function
[33]. While the example of FOXP2 shows that intracellu-
lar proteins, such as transcription factors, may be im-
portant targets of change, the function of proteins
present at the cell membrane, such as receptors, chan-
nels and adhesion proteins, is more straightforward to
quantify. Therefore, the bioinformatical strategy used in
the present study was to rank all proteins present on the
surface of human central nervous system cells by the
number of substitutions they have accumulated on the
human lineage. The aim of this strategy was to select a
neural cell surface protein with high probability of hav-
ing changed its function on the human lineage, so that
this functional change could be tested for in biological
model systems.
Results
Selection of candidate protein
A comparison of the protein-coding regions of the refer-
ence chimpanzee, orangutan and rhesus macaque ge-
nomes to 100 haploid human genomes, sampled from
diverse human populations, has been published before
[34] and resulted in a list of amino acid positions where
all modern human genomes agree with each other and
are different from the non-human primates. Almost half
of all human proteins contain at least one such amino
acid (Fig. 1).
The present study focuses on the substitutions occur-
ring in brain cell-surface proteins, i.e. the products of
genes annotated both as being expressed in central ner-
vous system cells and as present on the extracellular side
of the plasma membrane, according to Gene Ontology
[35]. Among 329 proteins in this set, 136 contain at least
one fixed human-specific difference (Fig. 1). An un-
known fraction of these human-specific substitutions
may have had functional consequences. While ideally
the functional consequences might be estimated from
the position of a substitution within the three-
dimensional structure of a protein, especially if
structure-function relationships are well established,
such structural data are not available for many of the
candidate proteins. Alternatively, reasoning that a
change in function may require several amino acid sub-
stitutions or that a change, once it has occurred, may re-
lease a functional restraint and permit additional
substitutions to occur, the 136 candidate proteins were
ordered by the number of fixed human-specific amino
acid differences, with β-protocadherin 11 (PCDHB11)
appearing at the top of the list, due to its 12 substitu-
tions (Table 1).
While a high number of substitutions does not neces-
sarily indicate a change in function, several aspects make
PCDHB11 stand out from other proteins on the list.
Higher numbers of substitutions would be expected to
occur by chance in longer proteins; the absolute number
was therefore divided by the length of the protein to ex-
clude this explanation. The high rate of substitutions in
several proteins, such as PCDH15, can readily be ex-
plained by their large size, but PCDHB11 continues to
stand out (Table 1). Furthermore, in exome compari-
sons, some amino acids are frequently found in substitu-
tion for each other, probably because their exchange has
a lower impact on the function of the protein. The rate
of amino acid exchange, when comparing proteins in
closely related species, was used in order to weigh the
importance of an exchange; amino acids that rarely sub-
stitute for each other were given higher weights. When
summing up the weights for all the substitutions,
PCDHB11 continues to have a score well above those of
all the other candidate proteins (Table 1), due to several
evolutionarily rare amino acid exchanges, e.g. asparagine
to isoleucine and arginine to isoleucine (Table 2).
Functional data show the importance of the distribu-
tion of the substitutions among the domains of the pro-
tein. Clustered protocadherins are proposed to serve as
adhesion proteins that may regulate synaptic contacts
between neurons [36, 37]. So far, the function of murine,
but not human, clustered protocadherins has been tested
in cell culture models and intact organisms [38–50]. In
cell culture, among six extracellular cadherin repeats,
one transmembrane and one cytoplasmic domain, the
Fig. 1 Pipeline for discovering human-specific amino acid
substitutions. Amino acids in human proteins were considered human-
specific wherever they differed from the consensus between
the exomes of Macaca mulatta, Pongo abelii and Pan troglodytes.
Differences were considered fixed if the human-specific amino acid
recurred in 100 haploid human genomes. Among those proteins that
could be aligned between the four genomes, the indicated number of
proteins contains at least one fixed human-specific difference
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ones most important for protocadherin specificity are
EC2 and EC3 [43], and nine of the changes in human
PCDHB11 are concentrated in these two domains
(Table 2), suggesting again that they might be relevant.
Very recently, crystal structures of the EC1-3 domains
of several murine protocadherins, among them the β-
protocadherin PCDHB1, have been published [51, 52].
By homology to the crystal structure of monomeric
PCDHB1 EC1-3 [51], all ten human-specific amino acids
in these domains of PCDHB11 are expected to be at
least partly exposed to water; such surface-exposed
amino acids are less constrained by the structure and
may therefore be more variable, unless they contribute
to dimer interfaces. In this regard, it is relevant to note
that Thr185 in the PCDHB1 structure, corresponding to
human-specific PCDHB11 Ser213, hydrogen bonds with
Thr143, which was shown to be necessary for protocad-
herin dimerization in a cell-based assay [51]. Further-
more, the residue corresponding to human-specific
PCDHB11 Ser134 contributes to crystal contacts in cer-
tain γ-protocadherins, and so do the EC2 β4-β5, the
Phe-X10-Phe loop and the EC3 β7 loop, which in
PCDHB11 are predicted to contain human-specific
Ile185, Phe281 and His336, respectively [52].
While crystal contacts are not evidence of functional
importance, and different clustered protocadherins may
dimerize slightly differently, the homologies mentioned
would suggest, on a purely structural basis, that some of
the human-specific mutations might affect the adhesivity
of PCDHB11. However, these putative conclusions from
bioinformatical investigation depend on functional
confirmation.
Functional test of human PCDHB11
Following an established protocol [43], human PCDHB11
and a well-investigated murine control, PCDHGA3, were
electroporated into the normally non-adhesive human
suspension cell line K562. Murine PCDHGA3 caused the
appearance of large cell clusters, as previously described
(Fig. 2c, f ); cells expressing human PCDHB11 formed
clusters, but smaller ones (Fig. 2b). The proportion of lar-
ger cell clusters among all cells was quantified in four
Table 1 Proteins on the surface of central nervous system cells that have accumulated the highest number of amino acid
substitutions on the human lineage
Protein Substitutions Length of protein Subst./length Weighted subst. Weighted subst./length
PCDHB11 12 797 0.015 89 0.112
ICAM1 6 532 0.011 41 0.077
HTR3E 4 456 0.009 33 0.072
HRH1 5 487 0.010 31 0.064
DRD5 5 477 0.010 30 0.063
PCDHB13 6 798 0.008 47 0.059
GLRA4 4 417 0.010 24 0.058
HOME3 2 361 0.006 19 0.053
PCDHB6 5 794 0.006 40 0.050
VIPR1 2 457 0.004 20 0.044
CCKAR 2 428 0.005 18 0.042
PCDHB12 4 797 0.005 30 0.038
OXYR 3 389 0.008 14 0.036
GRIN3A 6 1115 0.005 38 0.034
PCDHB10 3 797 0.004 27 0.034
SEMA5B 5 1151 0.004 32 0.028
PCDHA5 4 936 0.004 26 0.028
PCDHB14 4 798 0.005 21 0.026
GRIN2C 4 1236 0.003 32 0.026
PCDHA2 4 948 0.004 23 0.024
CD44 3 742 0.004 17 0.023
PCDHB15 4 787 0.005 18 0.023
PCDH15 9 1955 0.005 43 0.022
For each protein, the number of human-specific substitutions, divided by the length of the protein, gives the fraction of amino acids that have changed and
become fixed on the human lineage. For each amino acid substitution on the human lineage, a weight was derived from the BLOSUM100 matrix that reflects the
rareness of this exchange between organisms that have 99 % amino acid identity, and the weights of all substitutions were summed up for each protein
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independent transfections; the adhesive strength conferred
by human PCDHB11 was significant when compared to
negative controls, but significantly lower than that con-
ferred by murine PCDHGA3 (Fig. 2g, h).
The weak adhesivity of PCDHB11-transfected cells
might be explained by low expression levels. However,
the expression of PCDHB11 fused to green fluorescent
protein (GFP) was easily detected by Western Blot
(Fig. 3a). It has been shown that N-terminal hemaggluti-
nine (HA) tags, which allow selective staining of surface-
exposed proteins, do not reduce the adhesion mediated
by γ-protocadherins [43]. Reasoning that an N-terminal
HA-tag would also preserve any adhesion mediated by
PCDHB11, cells were transfected with HA-PCDHB11-
GFP or murine HA-PCDHGA3. HA-PCDHB11-GFP
was expressed at much lower levels (Fig. 3b), and this
was reflected in lower surface expression (Fig. 3e-g) and
a lower proportion of large cell clusters (Fig. 3c, d) than
with HA-PCDHGA3. Nevertheless, PCDHB11 was
expressed and reached the cell surface.
One reason for the low adhesivity of human
PCDHB11 would be a loss of function as consequence
of one or more of the mutations that occurred during
human evolution. In order to test for an effect of the
human-specific substitutions, a protein with reversion of
these substitutions to the consensus sequence of non-
human primate PCDHB11 proteins (Table 2) was syn-
thesized and expressed in K562 cells. This reverted
PCDHB11 had adhesive properties indistinguishable
from modern human PCDHB11 (Fig. 2b, e, g, h). While
it is not possible to exclude subtle changes, based on the
present data, a complete loss or gain of adhesivity, due
to the human-specific substitutions, can be refuted.
The properties of both reverted and modern human
PCDHB11 were also investigated by quantifying co-
clustering with other cells. Different populations of K562
cells were transfected with protocadherins and either
green or red fluorescent protein, and the two popula-
tions were mixed on the following day. As expected,
K562 cells without any protocadherin did not form clus-
ters (Fig. 4a), nor did cells transfected with a protocad-
herin form mixed clusters with negative controls
(Fig. 4b-d, e, i, m). Cells transfected with PCDHGA3 and
PCDHB11, respectively, did not adhere to each other,
which would manifest as a high proportion of mixed
clusters (Fig. 4h, l, n, o). However, two cell populations,
each transfected with murine PCDHGA3, adhered
strongly to each other, as expected (Fig. 4p). In mixtures
of modern and ancestral PCDHB11-expressing cells,
some mixed clusters were observed (Fig. 4f, g, j, k),
which were smaller than the PCDHGA3 clusters. The
co-occurrence of green and red cells in the same clusters
was quantified in each condition (Fig. 4q). PCDHB11-
expressing cells adhered more to each other than to
negative controls or to murine PCDHGA3. The human-
specific changes did not abolish the weak mutual
adhesion.
Intra-human variability in PCDHB11
Since these assays did not reveal a change in the adhe-
sion function of PCDHB11, the high number of human-
specific amino acid substitutions in PCDHB11 might be
thought to be due to a higher local mutational burden
or reduced purifying selection. Such processes would ne-
cessarily increase variability among humans. However, it
has been reported before, in an ethnically homogeneous
sample, that human PCDHB11 had lower variability
than other β-protocadherin genes [53]. Here, the num-
bers of non-synonymous minor alleles in all human β-
protocadherins were reanalyzed using dbSNP; they
ranged from 92 to 167 variable positions, and the num-
ber for PCDHB11 was 139, coincidentally the median of
the distribution (Fig. 5, open diamonds). This normal
intra-human variability of PCDHB11 stands in contrast
to the evolutionary data, where PCDHB11 has a much
higher number of human-specific amino acid substitu-
tions than any other β-protocadherin (Table 1; Fig. 5,
closed circles).
Discussion
The aim of this work was to search systematically for
the brain protein that has changed the most during
human evolution and that might contribute to
uniquely human brain function and pathology [23].
Table 2 Differences between non-human primate consensus
and human PCDHB11
Position Consensus Human Weight Domain
4 Glu Gln 3 Signal peptide
106 Phe Leu 5 EC1a
134 Leu Ser 11 EC2a
185 Asn Ile 12 EC2a
213 Thr Ser 3 EC2a
252 Pro Arg 10 EC3a
263 Thr Ile 8 EC3a
281 Leu Phe 5 EC3a
304 Thr Arg 8 EC3a
334 Arg Ile 12 EC3a
336 Gln His 4 EC3a
724 Arg Ser 8 Cytoplasmic
Differences between modern human PCDHB11 and the consensus of Macaca
mulatta, Pongo abelii and Pan troglodytes. Human is the consensus of 100
chromosomes, wherever it differs from the ancestral amino acid. Weight is
derived from the evolutionary rate of exchange of each amino acid pair (for
details see “Methods”). The table shows the amino acids in the constructs
used in the experiments; current data show that there is indeed variation
within modern humans at the signal peptide site. aEC1, EC2, EC3: extracellular
cadherin domains 1–3
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Evolutionary studies, such as the present one, might
help to pinpoint molecules important for human
functioning [54]. The most promising candidate from
the bioinformatical part of the work was the β-
protocadherin PCDHB11.
The β-protocadherin cluster, as a whole, was shown
to be rapidly diverging between humans and chim-
panzees [24]. According to the Allen Brain Atlas [55],
PCDHB11 mRNA is expressed in the human brain,
especially in the hippocampus, striatum, substantia
nigra and locus ceruleus [56]. Human PCDHB11 has
no direct murine homolog [57], but murine β-
protocadherin mRNAs are expressed combinatorially
in Purkinje cells [58]. At the protein level, some mur-
ine β-protocadherins have been shown to be
expressed in synapses of the central nervous system
[59, 60]. With regard to the physiological importance
of β-protocadherins, the only data in humans so far
have revealed a very high expression of PCDHB11
and PCDHB13 on the melanoma cell surface [61, 62].
Hypermethylation of promoters in the protocadherin
clusters, collectively, which is expected to downregu-
late gene expression, is a signal of Wilms’ tumor [63],





Fig. 2 Homophilic adhesion of PCDHB11 and PCDHGA3 in human suspension cells. GFP was electroporated alone (a) or in combination with
human PCDHB11 (b) or murine PCDHGA3 (c) into K562 cells; in the same way, mCherry was electroporated alone (d) or in combination with
reverted PCDHB11 (e) or murine PCDHGA3 (f). Scale bar: 250 μm. g Fraction of large clusters (>30 cells), medium clusters (10–30 cells) or small
clusters (<10 cells) in each condition. h Adhesive strength of cells in each condition as proportion of clusters with ≥ 10 cells, relative to the
condition with the same fluorescent protein and PCDHGA3. Error bars: standard error of mean. The three levels of protocadherin (none,
PCDHB11, PCDHGA3) were significantly different from each other (ANOVA, p = 0.0006; Tukey HSD test: none vs. PCDHB11, p = 0.036; none vs.
PCDHGA3, p = 0.0005; PCDHB11 vs. PCDHGA3, p = 0.026; n = 4 transfections)
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The most widely accepted model for the operation of
clustered protocadherins is homophilic adhesion, where
a hetero-oligomer of α-, β- and/or γ-protocadherins on
the surface of one cell binds to an oligomer of the exact
same composition on the surface of another cell [43, 48,
51]. While this homophilic binding can be measured as
the formation of cell clusters in the K562 cell line model,
in neurons it is proposed to lead to synapse disruption
and therefore dendritic self-avoidance, optimizing the
coverage of a neuron’s territory [46, 51]. The present
data extend this established cell culture model for the
first time to a human protocadherin. Human PCDHB11
does induce the formation of K562 cell clusters, but at a
very low level, and this low adhesivity has apparently
been characteristic of PCDHB11 since before the diver-
gence of human and chimpanzees. It is unclear if such a
low level of adhesivity has functional relevance in the in-
tact organism.
As homophilic adhesion is the main function of clus-
tered protocadherins investigated experimentally so far,
these results discourage a functional interpretation of
the human-specific substitutions and require considering
neutral evolution of this locus [68]. However, the unre-
markable intra-human variability of PCDHB11 suggests
that there is no mutational hot spot at work, nor have
selection constraints on PCDHB11 been specially re-
laxed. No exon of PCDHB11 was found to have high
levels of biased gene conversion [69]. Moreover, while
gene conversion events in certain human protocadherins
have been reported, these events concentrated on the
EC6 and cytoplasmic domains, sparing the EC1-EC3 do-
mains [70]. Nine of twelve changes in PCDHB11 are lo-
cated in EC2 and EC3, and it has been suggested, in a
joint analysis of all human protocadherins, that posi-
tively selected positions are concentrated in these do-
mains [71]. Finally, we note that the lack of increased
intra-human variability also seems to discourage the hy-
pothesis of diversifying selection.
While some other neutral process may yet explain the
high density of human-specific substitutions in
PCDHB11, it is also possible that selection might have
occurred on an as yet unknown function of human
PCDHB11. The subcellular localization of chick α-
protocadherins [72] and rodent and primate β-
protocadherins [59, 60] was suggested to be incompat-
ible with the commonly assumed homophilic adhesion
function. While no data on possible trans-interaction




Fig. 3 Expression of protocadherins. GFP was electroporated alone or in combination with protocadherins into K562 cells. a Immunoblotting of
cell lysates with anti-GFP shows bands compatible with the expected molecular weights for GFP (27 kDa) and mature PCDHB11-GFP (110 kDa);
image representative of three transfections. b Immunoblotting of cell lysates with anti-HA shows bands compatible with the expected molecular
weights for mature HA-PCDHB11-GFP (113 kDa) and HA-PCDHGA3 (99 kDa); image representative of two transfections. c Proportion of medium
and large clusters was lower in HA-PCDHB11-GFP-transfected than in HA-PCDHGA3-transfected cells, but higher than in control cells (n = 10-12
images per condition). d Proportion of medium to large cell clusters when normalized by HA-PCDHGA3. For visualization of surface
protocadherins, live cells transfected with GFP alone (e) or in combination with HA-PCDHB11-GFP (f) or HA-PCDHGA3 (g) were stained with anti-
HA-biotin and streptavidin-Alexa555, then fixed. Blue: DAPI. Green: GFP. Red: surface HA-tagged protocadherins. Scale bar: 10 μm
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Fig. 4 Specificity of adhesion of PCDHB11. Different populations of K562 cells were separately electroporated as in Fig. 2, where one population
received GFP and a protocadherin, and the other mCherry and a protocadherin. Green and red populations were mixed 24-48 h later, rocked for
2 h and then photographed while still alive. a-p The identity of the protocadherins in the green and red populations are indicated. Scale bar:
250 μm. q For each pair of cell populations, the conditions with switched fluorophores were joined, and the proportion of mixed clusters
(containing both red and green cells) was expressed as fraction of all clusters. In an overall 2-way ANOVA, the identity of the cell populations and
their interaction were each highly significant (n = 17-84 images per condition, p < 10- 8). In each subpanel, the identity of the second cell
population was significant (ANOVA, p < 0.05). In each subpanel, the second cell populations were significantly different from control where
indicated (linear models with Bonferroni correction for comparison with control; *:p < 0,05; **: p < 0.01; ***: p < 0.001)
de Freitas et al. BMC Evolutionary Biology  (2016) 16:75 Page 7 of 11
adhesion to integrin has been proposed for murine α-
protocadherins [49], and additional intracellular roles
distinct from cell adhesion have been suggested for some
murine γ-protocadherins [39, 41, 42].
Conclusion
The strategy employed here resulted in the discovery of
PCDHB11 as a candidate gene for positive selection on
the human lineage, combining a high number of poten-
tially relevant substitutions on the human lineage with
low intra-human variability. In spite of these genetic re-
sults, cell-based tests on the only proposed function for
PCDHB11 did not indicate a functional change. If the
molecular bases of human cognitive capacities can in-
deed be pinpointed to specific parts of the genome, they
may well be discovered in changes affecting expression




A list of genome positions where a panel of 100 human
haploid genomes agrees on one base, while the reference
genomes of common chimpanzee (Pan troglodytes),
orangutan (Pongo abelii) and rhesus macaque (Macaca
mulatta) agree on a different base, was kindly supplied
by Martin Kircher [34]. For the existing sequence data,
such a procedure was considered more prudent than
classification of amino acid positions into different vari-
ability classes [73], both because of the small phylogenies
and because structural information is not available for
all proteins in the set. Human proteins where this base
difference resulted in an amino acid difference were
retained for further analysis if they were associated with
the Gene Ontology terms [74]:
(1)“integral component of plasma membrane” or
“anchored component of external side of plasma
membrane”, and additionally
(2)any term beginning with “nervous”, “neuron”,
“dendr”, “axon” or “synap” (except for those
containing “enteric”, “autonomous”, “synaptonem”,
“axonem” or “dendritic cell”).
Since the surface annotation in this data base was in-
complete, all members of a protein family (defined as
those proteins having UNIPROT codes [75] beginning
with the same three letters) were included if at least one
member had passed the cell surface filter. The 329
resulting proteins were ranked by number of amino acid
substitutions and also by number of substitutions nor-
malized to the length of the protein.
The BLOSUM100 matrix gives the rate of one amino
acid being exchanged for another one when calibrated
for protein sequences of >99 % identity [76], correspond-
ing to the overall identity between human and chimpan-
zee proteins [24]; the matrix was converted into weights,
so that the most common exchanges had a weight of 3
and the least common exchange a weight of 15. These
weights were added up for all differences in each pro-
tein. Furthermore, the weighted number of differences
was normalized by the length of the protein. To test the
reliability of the ranking, the same procedure was re-
peated with the BLOSUM62 matrix (which is more
commonly used) and with the JTT matrix (which was
suggested by PROTTEST [73] as the best model for an
evolutionary tree of PCDHB11), and changing the matrix
did not strongly affect the ranking. All analyses were
done using custom-written Python scripts.
For examination of surface exposure, human PCDHB11
and all protocadherins discussed in references [51, 52]
were aligned using Clustal Omega [77]. The amino acids
that correspond to human-specific PCDHB11 substitu-
tions were localized in structure 4ZPL (murine PCDHB1,
the nearest homolog that has been crystallized), 4ZI9
(murine PCDHGC3) and 4ZI8 (murine (PCDHGA1).
Molecular biology
Human PCDHB11 cDNA was ordered from imaGenes
(Berlin, Germany), amplified by PCR using primers
containing NheI and BamHI sites, and cloned into
pEGFP-N1, so that GFP was added in frame at the
C-terminus. HA-tagged PCDHB11-GFP was con-
structed by cloning annealed oligonucleotides coding
for the HA-tag YPYDVPDYAE (Lifetech, São Paulo,
Fig. 5 Intra-human variability of PCDHB11 is not elevated. For each
protein in the human PCDHB cluster, the number of positions
subject to intra-human variability is shown as black open diamonds
(scale on left axis) and the number of substitutions on the human
lineage as red full circles (scale on right axis, same data as in Table 1).
Shaded grey bar: PCDHB11
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Brasil) after the signal peptide cleavage site of
PCDHB11. A reverted version was constructed by
substituting the 12 consensus bases of the other pri-
mates into the human PCDHB11-GFP sequence,
which was then ordered from Genscript (Piscataway,
NJ). The plasmids pcDNA3-HA-MmPCDGA3 and
pmRFP-MmPCDGA3, coding for Mus musculus γ-
protocadherin A3, were a kind gift from Dr. Dietmar
Schreiner. All constructs were checked by Sanger se-
quencing of the entire open reading frame (Sequen-
cing Core Facility, Institute of Biophysics, Federal
University of Rio de Janeiro).
The number of variable positions in modern humans
was calculated for each member of the PCDHB cluster
as the sum of missense, nonsense, stop lost and frame
shift mutations in dbSNP [78].
Cell culture
K562 cells, an immortalized cell line derived from hu-
man leukemia [79], were a kind gift of Martin Bona-
mino, National Institute for Cancer Research, Rio de
Janeiro, Brasil. K562 cells were cultured in a rich
medium [80], and 2 · 106 cells were electroporated with
1 μg of pEGFP-N1 or membrane-anchored mCherry
plus 5 μg of the indicated protocadherin plasmid DNA,
using “1 M” buffer and Mirus Biotech (Madison, WI) or
Bio-Rad (São Paulo, Brasil) cuvettes on a Nucleofector II
(Lonza, Basel, Switzerland) [80]. Immediately after elec-
troporation, cells were resuspended in 1 ml of the cul-
ture medium and diluted to 8 ml in warm culture
medium. On the following day, where indicated, cells
from different electroporation conditions were mixed 1:1
in 6-well plates. The plates were rocked for at least 2 h
at 37 °C and 5–6 movements per minute, and 5–10
fields of view in each well were photographed on an
Eclipse TE300 microscope using a 10x magnifying ob-
jective and a DS-QiMC camera (Nikon, Melville, NY).
For immunoblotting, transfected cells were centri-
fuged 10 min at 200 g, 37 °C, and the supernatants
were resuspended in radioimmunoprecipitation assay
(RIPA) buffer including protease inhibitors (Thermo
Fisher Scientific, Waltham, MA). 100 μg (for GFP) or
20 μg (for HA) of total protein were applied per well
of a 6-15 % gradient Tris-Glycine gel (Bio-Rad La-
boratories, Hercules, CA), and after eletrophoresis
transferred to a nitrocellulose membrane (GE Health-
care, Little Chalfont, UK). For GFP detection, mem-
branes were incubated with a rabbit polyclonal
antibody (Life Technologies, A-11122) diluted 1:2000
in 50 mM Tris, 100 mM NaCl, 0.1 % Tween 20,
pH 7.4, with 3 % bovine serum albumine (Sigma, St.
Louis, MO) and a horse-radish peroxidase-conjugated
anti-rabbit secondary antibody (Invitrogen, Waltham,
MA), while for HA revelation, they were incubated
with biotinylated 3 F10 rat monoclonal antibody
(Roche Life Science, Indianapolis, IN) diluted 1:500 in
the same buffer, and streptavidin-horseradish peroxid-
ase (Invitrogen, Waltham, MA). All membranes were
revealed on a ChemiDoc system (Bio-Rad) using
Super Signal West Femto (Thermo Fisher Scientific).
For HA staining, live K562 cultures were incubated for
one hour with the biotinylated 3 F10 anti-HA, then for
40 min with streptavidin-Alexa555, both diluted 1:250 in
culture medium at 8 °C, then fixed for 15 min in 4 % para-
formaldehyde, 4 % sucrose in phosphate-buffered saline at
8 °C, deposited on slides using a CytoSpin (Thermo Fisher
Scientific) and mounted in ProLong containing 4′,6-dia-
midino-2-phenylindole (DAPI; Invitrogen). Images were
taken on an Axiovert 200 M microscope, using a 100x ob-
jective (Zeiss, Göttingen, Germany).
Quantification
For quantification of aggregate size, cell clusters were
thresholded in ImageJ 2.0.0 [81] using the triangle algo-
rithm implemented in the AutoThreshold plugin for Ima-
geJ [82], and all areas of at least 100 pixels were exported
for analysis in R [83]. From the size of a single cell, defined
as the mode cluster size of 150 pixels for control GFP-
transfected cells, the cutoff for clusters of 10 cells was cal-
culated as 696 pixels (assuming spherical clusters), and for
clusters of 30 cells as 1448 pixels. For statistical analysis,
the fraction of clusters containing at least 10 cells was cal-
culated for each condition and day. After normalizing
each condition on each day to the PCDHGA3 condition
on the same day with the same fluorophore, there was no
significant difference in fraction of medium and large clus-
ters between human and reverted PCDHB11 (n = 4 trans-
fections). The two control conditions, the two PCDHB11
conditions and the two PCDHGA3 conditions were there-
fore pooled for further analysis.
For quantification of adhesion specificity, the separate
green and red channels of each field were auto-
thresholded as above, and the two masks were added.
The presence of thresholded green and red cells was re-
corded for each cluster. In R, the proportion of clusters
containing both green and red cells, relative to all clus-
ters, was calculated for each image.
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